文献速递神经核医学肿瘤 PET/CT

肿瘤与血池比值评估神经内分泌肿瘤生长抑素受体密度的研究

Tumor-to-Blood Ratio for Assessment of Somatostatin Receptor Density in Neuroendocrine Tumors Using 68Ga-DOTATOC and 68Ga-DOTATATE.
PubMed 文献 · J Nucl Med · 2019-07-13

结果显示Ki与TBR呈线性相关,68Ga-DOTATOC和68Ga-DOTATATE的Pearson相关系数平方分别为0.98和0.93。结论认为TBR比SUV更准确反映生长抑素受体密度,建议作为半定量评估的首选指标。

要点

  • TBR与Ki高度线性相关,68Ga-DOTATOC的R²为0.98,68Ga-DOTATATE的R²为0.93。
  • 肿瘤SUV与Ki不相关,不能准确反映生长抑素受体表达。
  • TBR被建议作为68Ga-DOTATOC和68Ga-DOTATATE肿瘤摄取半定量评估的首选指标。

核心结论

  • TBR与Ki高度相关,比SUV更准确反映生长抑素受体密度,建议作为半定量评估首选指标。

研究设计与样本

  • 采用Patlak法测定Ki,计算40至45分钟间隔的TBR。

主要发现

  • Ki与TBR呈线性关系,68Ga-DOTATOC的Pearson相关系数平方为0.98。
  • 68Ga-DOTATATE的Pearson相关系数平方为0.93。

关键数值与推荐

  • TBR计算时间间隔为40至45分钟。
  • 68Ga-DOTATOC的Ki与TBR线性相关R²=0.98,68Ga-DOTATATE为R²=0.93。

临床怎么用

  • 在神经内分泌肿瘤68Ga-DOTATOC或68Ga-DOTATATE PET/CT中,可用TBR替代SUV进行半定量评估。
  • TBR可作为治疗监测工具,更准确反映生长抑素受体密度变化。

局限性

  • TBR仅基于40至45分钟动态PET/CT数据计算。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PET/CT with 68Ga-DOTA-somatostatin analogs has been tested for therapy monitoring in patients with neuroendocrine tumors (NETs). However, SUVs in tumors do not correlate with the net influx rate (Ki), as a representation of the somatostatin receptor expression. In this study, tumor-to-blood ratio (TBR) was evaluated as an alternative tool for semiquantitative assessment of 68Ga-DOTATOC and 68Ga-DOTATATE tumor uptake and as a therapy monitoring tool for patients with NETs. Methods: Twenty-two NET patients underwent a 45-min dynamic PET/CT scan after injection of 68Ga-DOTATOC or 68Ga-DOTATATE. Ki was determined using the Patlak method, and TBR was calculated for the 40- to 45-min interval. Results: A linear relation was found between Ki and TBR, with a square of Pearson correlation of 0.98 and 0.93 for 68Ga-DOTATOC and 68Ga-DOTATATE, respectively. Conclusion: A high correlation was found between Ki and TBR. Hence, TBR reflects somatostatin receptor density more accurately than SUV and is suggested as the preferred metric for semiquantitative assessment of 68Ga-DOTATOC and 68Ga-DOTATATE tumor uptake.

来源:J Nucl Med,查看原文。版权归原作者所有。

引用

  1. Ilan E, Velikyan I, Sandström M, et al. Tumor-to-Blood Ratio for Assessment of Somatostatin Receptor Density in Neuroendocrine Tumors Using 68Ga-DOTATOC and 68Ga-DOTATATE. J Nucl Med. 2019. PMID: 31302632. doi:10.2967/jnumed.119.228072

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。